Toggle navigation
Home
Search
Services
Blog
Contact
About
Clinical Evaluation of Biological Response Modifiers
Neefe, John R.
Georgetown University, Washington, DC, United States
Search 6 grants from John Neefe
Search grants from Georgetown University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Eradication of MYCN-amplified neuroblastoma by targeting the interaction between a long noncoding RNA and its binding protein
Community Outreach and Education Program
Marc Undergraduate Student Training in Academic Research
Nurse Anesthetist Traineeships
Develop Methods of Analysis of Human Colostrum and Milk
Recently added grants:
Tissue-Engineered Models of Microvessel-Mediated Glioblastoma Invasion
Targeting cancer stem cells in JAK2V617F induced neoplasm
Teen Mothers? Prenatal Cannabis Use and Co-Use with Tobacco
Training Institutes for mobile health (mHealth) methodologies
Decoding parametric attributes of auditory working memories from human brain activity
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM007437-001009
Application #
3608505
Study Section
Project Start
1980-09-30
Project End
Budget Start
1985-09-01
Budget End
1985-12-31
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Institution
Name
Georgetown University
Department
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Related projects
NIH 1986
N01 CM
Clinical Evaluation of Biological Response Modifiers
Neefe, John R. / Georgetown University
NIH 1985
N01 CM
Clinical Evaluation of Biological Response Modifiers
Neefe, John R. / Georgetown University
Publications
Neefe, J R; Phillips, E A; Treat, J
(1986)
Augmentation of natural immunity and correlation with tumor response in melanoma patients treated with human lymphoblastoid interferon.
Diagn Immunol 4:299-305
Comments
Be the first to comment on this grant